Ovarian Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cancer, including details on symptoms, causes, treatment, information.

Volume 4 (2007), Issue 8 (August)

1. Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc.
   Obstet Gynecol, 110(2): 498-501. [Abstract] [Full-text]
2. Ovarian metastasis from colorectal cancer: prognostic value of radical oophorectomy.
   J Surg Oncol, 96(2): 113-7. [Abstract] [Full-text]
3. Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database.
   J Surg Oncol, 96(2): 102-12. [Abstract] [Full-text]
4. Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways.
   Cancer Lett, 254(2): 217-26. [Abstract] [Full-text]
5. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
   Cancer, 110(4): 791-800. [Abstract] [Full-text]
6. Extended cytoreduction of intraabdominal metastatic ovarian cancer in the left upper quadrant utilizing en bloc resection.
   Am J Obstet Gynecol, 197(2): 209.e1-4; discussion 209.e4-5. [Abstract] [Full-text]
7. Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer.
   Am J Obstet Gynecol, 197(2): 199.e1-4; discussion 199.e4-5. [Abstract] [Full-text]
8. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors.
   Fertil Steril, 88(2): 479-84. [Abstract] [Full-text]
9. Struma ovarii coincident with Hashimoto's thyroiditis: an unusual cause of hyperthyroidism.
   Fertil Steril, 88(2): 497.e15-7. [Abstract] [Full-text]
10. Cyclin E-associated kinase activity predicts response to platinum-based chemotherapy.
    Clin Cancer Res, 13(16): 4800-6. [Abstract] [Full-text]
11. High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications.
    Clin Cancer Res, 13(16): 4731-9. [Abstract] [Full-text]
12. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    J Clin Oncol, 25(24): 3621-7. [Abstract] [Full-text]
13. An early signal of CA-125 progression for ovarian cancer patients receiving maintenance treatment after complete clinical response to primary therapy.
    J Clin Oncol, 25(24): 3615-20. [Abstract] [Full-text]
14. Dysgerminoma in a child with ataxia-telangiectasia.
    Pediatr Hematol Oncol, 24(6): 431-6. [Abstract] [Full-text]
15. Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells.
    Biochem J, 406(3): 427-36. [Abstract] [Full-text]
16. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer.
    Int J Cancer, 121(8): 1830-8. [Abstract] [Full-text]
17. Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells.
    Cancer Lett, 255(2): 182-93. [Abstract] [Full-text]
18. The synergistic effects of CXCR4 and EGFR on promoting EGF-mediated metastasis in ovarian cancer cells.
    Colloids Surf B Biointerfaces, 60(1): 1-6. [Abstract] [Full-text]
19. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.
    J Clin Oncol, 25(25): 3985-90. [Abstract] [Full-text]
20. Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary.
    Cancer Sci, 98(10): 1586-91. [Abstract] [Full-text]

© 2004-2008 Ovarian Cancer Research Today. All Rights Reserved.